Since genetic overexpression of Foxf1 in endothelial cells attenuated pulmonary fibrosis, we next tested whether nanoparticle delivery of Foxf1 cDNA into endothelial cells can be a therapeutic approach to inhibit lung fibrosis. This evidence concerns the gene FOXF1 and pulmonary fibrosis.